CorePath partners with a small number of early-stage MedTech teams each year to build the commercial strategy, story, and execution path required to move from development to market.
What We Do
CorePath engagements are built around strategy + execution. Roughly half of our value is commercial planning and narrative clarity; the other half is building and running the launch and sales operation itself.
We adapt the engagement to the company’s stage—from pre-launch through relaunch or early scale.
-
This work defines what success looks like and prevents costly mis-sequencing.
Clear value story and positioning
Target customer, segment, and use-case definition
Commercial milestones aligned to clinical evidence, regulatory status, and financing
High-level pricing, access, and reimbursement considerations
Go-to-market and channel strategy options
-
If the story isn't clear and credible, execution stalls.
Brand and messaging platform
Website and investor narrative framework
Core commercial assets (decks, one-pagers, education tools)
Clinical-to-commercial storytelling aligned to claims boundaries
-
If the story isn't clear and credible, execution stalls.
Brand and messaging platform
Website and investor narrative framework
Core commercial assets (decks, one-pagers, education tools)
Clinical-to-commercial storytelling aligned to claims boundaries
-
The wrong sales team — or the right team deployed at the wrong time — can destroy momentum. CorePath helps companies build the right commercial muscle, at the right moment.
Access to a deep network of elite MedTech sales reps, managers, and commercial leaders
Recruitment or deployment of the right talent for the stage (1099, contractor, or full-time)
Interim leadership or hands-on sales management
Coaching, performance management, and optimization
Engagement Flexibility
CorePath commonly supports:
First-time launches
Relaunches of Products
Expansion from Pilot Sales
Launch should ignite — not scramble.
Selective by Design
Senior Commercial Leadership
Integrate with Founders, CEOs, and Boards
Sequence Work for Clinical, Regulatory, and Financial Realities
No Overbuilding
CorePath only engages when there is a clear fit:
in stage, ambition, integrity, and potential for real value creation.
If we don’t believe we can materially improve outcomes, won’t take the work.